CHNA Fees and Costs — Loncar China BioPharma ETF
Data updated: 2023-11-14
The net expense ratio is 0.79%. There are no sales loads or redemption fees. In fiscal 2023 the fund paid $1K in broker commissions, 0.0275% of average net assets, and portfolio turnover was 27%.
CHNA Fees and Expenses
Annual operating expenses and sales charges of CHNA. Prospectus, as of December 31, 2022.
| Annual operating expenses | |
|---|---|
| Management fee | 0.79% |
| 12b-1 fee | 0.00% |
| Other expenses | 0.00% |
| Gross expense ratio | 0.79% |
| Fee waiver | — |
| Net expense ratio | 0.79% |
| Sales charges | |
|---|---|
| Max front load | — |
| Max deferred load | — |
| Redemption fee | — |
| Expense limitation in place (N-CEN) | No |
| Fees waived or reduced during the year | No |
| Waived fees subject to recoupment | No |
CHNA Costs Over Time
On $10,000 invested in CHNA, assuming 5% a year before costs, total costs come to $513 over 5 years, cutting the return by 0.86% a year. Illustration, not a forecast: it assumes today's net expense ratio throughout (a fee waiver may end).
| $10,000 invested | Sell after 1 year | Sell after 3 years | Sell after 5 years |
|---|---|---|---|
| Value before costs | $10,500 | $11,576 | $12,763 |
| Fund expenses (net expense ratio 0.79%) | $83 | $259 | $451 |
| Trading costs (broker commissions) | $3 | $9 | $16 |
| Lost growth on money paid in costs | $0 | $13 | $47 |
| Total costs | $86 | $282 | $513 |
| Value after costs | $10,414 | $11,295 | $12,250 |
| Impact on return, per year | 0.86% | 0.86% | 0.86% |
CHNA Trading Costs
Brokerage costs reported on SEC Form N-CEN for the fiscal year ending August 31, 2023.
- Explicit cost rate (commissions ÷ average net assets): 0.0275%
- Total broker commissions: $1K
- Bought from dealers (principal trades, not a cost): —
- Portfolio turnover (prospectus): 27%
- Securities lending: none during the year
CHNA Agency Brokers
Commissions paid.
| Broker | Amount | Share |
|---|---|---|
| MISCHLER FINANCIAL GROUP, INC. | $1K | 88.05% |
| J.P. MORGAN SECURITIES LLC | $161 | 11.52% |
| GOLDMAN SACHS & CO. LLC | $6 | 0.43% |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.